GlaxoSmithKline PLC Director/PDMR Shareholding (4141F)

TIDMGSK

RNS Number : 4141F

GlaxoSmithKline PLC

20 February 2018

GlaxoSmithKline plc (the 'Company')

Shares sold to meet tax liabilities

Following the vesting of the pre-tax awards granted in 2015 under the GlaxoSmithKline Deferred Annual Bonus Plan ('DABP') on 15 February 2018 and as notified on 16 February 2018, the notifications that follow reflect change in the interests of the Person Discharging Managerial Responsibilities ('PDMRs') in American Depositary Shares ('ADS') of the Company arising from the sale of ADSs to meet tax liabilities.

Transaction notification

 
 1.    Details of PDMR/person closely associated 
        with them ('PCA') 
====  ============================================================ 
 a)    Name                    Mr D E Troy 
====  =======================  =================================== 
 b)    Position/status         SVP & General Counsel 
====  =======================  =================================== 
 c)    Initial notification/   Initial notification 
        amendment 
====  =======================  =================================== 
 2.    Details of the issuer, emission allowance 
        market participant, auction platform, auctioneer 
        or auction monitor 
====  ============================================================ 
 a)    Name                    GlaxoSmithKline plc 
====  =======================  =================================== 
 b)    LEI                     5493000HZTVUYLO1D793 
====  =======================  =================================== 
 3.    Details of the transaction(s): section 
        to be repeated for (i) each type of instrument; 
        (ii) each type of transaction; (iii) each 
        date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================ 
 a)    Description              GlaxoSmithKline plc American 
        of the financial         Depositary Shares ('ADSs') 
        instrument               ISIN: US37733W1053 
====  =======================  =================================== 
 b)    Nature of               The sale of ADSs to meet tax 
        the transaction         liabilities further to the vesting 
                                of awards granted in 2015 under 
                                the Company's 2009 Deferred Annual 
                                Bonus Plan-Deferred Bonus and 
                                Matching Awards. 
====  =======================  =================================== 
 c)    Price(s) and              Price(s)   Volume(s) 
        volume(s)                ---------  ----------------- 
                                  $37.4803   3,480 (Deferred) 
                                 ---------  ----------------- 
                                  $37.4803   2,520 (Matching) 
                                 ---------  ----------------- 
====  =======================  =================================== 
       Aggregated 
 d)     information 
   Aggregated 
    volume Price                 6,000 
                                  $37.4803 
 ============================  =================================== 
 e)    Date of the             2018-02-16 
        transaction 
====  =======================  =================================== 
 f)    Place of the            New York Stock Exchange (XNYS) 
        transaction 
====  =======================  ===================================

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHXBLFLVLFFBBE

(END) Dow Jones Newswires

February 20, 2018 08:16 ET (13:16 GMT)

Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2024 a Apr 2024